PureCycle Technologies (PCT) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
6 Aug, 2026Executive summary
Revenue for Q2 2026 reached $4.5 million, marking the sixth consecutive quarter of sequential growth and a 173% year-over-year increase, driven by increased customer adoption, production ramp-up, and regulatory tailwinds.
Completed a major turnaround at the Ironton facility ahead of schedule and below budget, improving reliability, throughput, and production consistency.
First commercial resin deliveries to P&G began, with additional branded products and seven new customer conversions expanding reach across multiple sectors.
Regulatory approval in New Jersey and California accelerated customer qualification and commercial ramp, especially in QSR and food service markets.
Liquidity strengthened to $236.9 million at quarter-end, supporting ongoing operations and expansion plans.
Financial highlights
Net loss for Q2 2026 was $142.2 million, a slight improvement from $144.2 million in Q2 2025; operating loss improved to $41.3 million from $45.6 million year-over-year.
Adjusted EBITDA was $(31.7) million, reflecting lower non-cash add-backs rather than operational decline.
Monthly core operations spending declined 8% year-over-year to $8.3 million.
Cash, restricted cash, and marketable securities totaled $236.9 million as of June 30, 2026.
Revenue for the quarter was $4.5 million, up from $1.7 million in Q2 2025.
Outlook and guidance
Branded sales volumes and production are expected to accelerate in the second half as regulatory deadlines approach and customer qualifications convert to volume.
Ironton breakeven remains a target for the second half of 2026.
Thailand facility groundbreaking is expected in 2H 2026, with operations targeted for 2028; project financing is progressing with financial close targeted by year-end.
Fiscal year 2026 project spend is expected to be $45–$50 million, mainly for Antwerp and Thailand projects.
Liquidity is projected to be sufficient for at least the next 12 months, with additional capital raises possible for long-term growth.
Latest events from PureCycle Technologies
- Record production and revenue growth, with robust liquidity and strong commercial momentum.PCT
Q1 2026 - Virtual meeting to elect nine directors, ratify auditor, and approve executive pay.PCT
Proxy filing - Annual meeting covers director elections, auditor ratification, executive pay, global growth, and ESG milestones.PCT
Proxy filing - Proposal seeks to lower the warrant Redemption Trigger Price and extend expiration to 2027.PCT
Proxy filing - Gen 2 technology and regulatory shifts position the company for rapid growth and global expansion.PCT
The 38th Annual Roth Conference - Proposal seeks to lower warrant trigger price and extend expiration, pending majority consent.PCT
Proxy Filing - Record production, new funding, and strong trials set stage for growth despite ongoing losses.PCT
Q3 2024 - First $1.6M revenue, 90% uptime, BOPP breakthroughs, and $59M+ capital raised in Q1 2025.PCT
Q1 2025 - Operational and commercial milestones, funding, and strong demand drive growth outlook.PCT
Q4 2024